Dyrk as modifiers of the apc and axin pathways and methods of use

Details for Australian Patent Application No. 2004210961 (hide)

Owner Exelixis, Inc.

Inventors Morablanco, Eva Lorena; Heuer, Timothy S.; Lickteig, Kim; Gendreau, Steven Brian

Agent Davies Collison Cave

Pub. Number AU-A-2004210961

PCT Pub. Number WO2004/072257

Priority 60/447,358 11.02.03 US

Filing date 10 February 2004

Wipo publication date 26 August 2004

International Classifications

C12N 015/00 Mutation or genetic engineering

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/072257 Priority application(s): WO2004/072257

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210964-Stimuli-responsive polymer conjugates and related methods

2004210957-Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex